FDA Approved Prepopik Bowel Prep Shows High Patient Tolerance

Share on Facebook
Prepopik, a low-volume bowel preparation for colonoscopies, received FDA approval last year and in the latest study of its use 58.4 percent of patients found the solution "very easy" to take, while 29 percent of patients found it "easy," according to a Gastroenterology & Endoscopy News report.

Sign up for our FREE GI E-Weekly for more coverage like this sent to your inbox!

The Ferring Pharmaceuticals prep, made of 10 grams of sodium picosulfate, 3.5 grams of magnesium oxide and 12 grams of citric acid, is to be administered in two five-ounce glasses and followed with clear liquids. Patients consume a total of two liters.  

More Articles on Gastroenterology:
UCLA Health System Opens New Specialty Services Practice, Including Gastroenterology
Gastrointestinal Device Market Estimated at $33B by 2023
FDA Grants 510(k) Clearance for Invendo Medical Single-Use Colonoscopy System


© Copyright ASC COMMUNICATIONS 2014. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

New From Becker's GI & Endoscopy

New data supports efficacy of Fuse endoscopy system

Read Now